Presentation at the event 'Innovative development and humanitarian assistance' in Copenhagen in June 2017; organized by the Confederation of Danish Industry and UNDP
The Innovation team is based across all 5 Regional Hubs and HQ.
This team is tasked with scanning the horizon: identifying promising approaches, solutions and technologies that are out there, perhaps used by the private and public sector, and to bring them to UNDP, to Country Offices to test them.
At UNDP we ‘disrupt’ business as usual, encourage change in the search for ever greater effectiveness, and identify new ways of doing things which could be of wide benefit.
Launched in June 2014, the UNDP Innovation Facility is a global mechanism to support innovation for development – effectively the “home” of UNDP’s drive to systematically innovate.
This includes catalytic seed capital - between US$20,000 and US$160,000 for R+D
Idea for a mobile application that leveraged data science to identify items people wanted to dispose of when they take a picture of them, give them a quote for how much worth, and business promise that someone will come & pick it up to safely dispose it.
Developed the idea through user validation, iteration, before realizing product-market fit and scaling 22 cities in China, and looking to global expansion
Image: Baidu Recycle
Control Group: 876
Treatment Group: 716
Funded by John D. and Catherine T. MacArthur Foundation.
ICS–Africa (Investing in Children and their Societies - Africa), a Dutch NGO, operationalized the delivery system and payment of the subsidy.
Source: http://www.poverty-action.org/study/nudging-farmers-use-fertilizer-experimental-evidence-kenya
TB remains a challenge for the public health despite the best efforts by all involved as Moldova failed to deliver on its commitments on MDG 6: according to WHO Moldova has one of the highest documented levels of TB and multi-drug resistant-TB in Europe (10.5 mortality rate per 100,000 persons). The Global Fund to Fight AIDS, Tuberculosis and Malaria ranks the country second among 110 countries by level of funds provided per capita. Among the primary concerns is the increasing rate of the multidrug-resistant tuberculosis , which is much trickier and more expensive to treat. One of the major reasons for this is the low drug adherence rate - people tend to discontinue treatment once they leave the hospital. With TB treatment basically free it is completely counter-intuitive that some people quit treatment and put their and others lives at risk.
This is exactly the issue where modern development agencies should help: not simply bring money and implement projects, but draw on the available expertise networks and build partnerships to work with the national counterparts to develop a solution relevant in Moldovan context. And this is how our joint work with the Ministry of Health and Behavioral Insights Team (formerly the UK Cabinet Office) has started. We began investigating why exactly TB patients drop out once they are released from hospitals?
Our ultimate hypothesis is that the way post-hospital treatment is organized, i.e. need to daily commute to clinic to swallow the pill in front of the doctor (so-called directly observed treatment, DOT), simply drives up the patients’ friction costs. That’s expensive, time-consuming, and furthermore since side effects of the drugs include nausea and fatigue, totally exhausting… One of the ways to overcome these frictions costs is video observed treatment (VOT), where patients swallow pills in front of webcam instead of daily commuting. VOT would make the lives of patients more comfortable and save doctors time by easing the flow of patients. It would also allow for covering more migrant workers and perhaps cut costs in the long term.
This has been our hypothesis and it would remain the hypothesis without a test. Indeed, we cannot advocate for changes in the existing national protocols without having robust evidence. How can we get it? We decided to set up the Randomized Control Trial (RCT). In a nutshell, idea is the following: we randomly divide a cohort of statistically similar TB patients in Chisinau in two groups: “control group”, which follows standard procedure, and “treatment group”, which follows our new VOT procedure. After the treatment period is finished we compare the results and if we see that drug adherence rate is higher in “treatment group” it means VOT procedure works and can become viable alternative to the standard DOT. And thus it can save many human lives and public money.
Control Group: 876
Treatment Group: 716
Funded by John D. and Catherine T. MacArthur Foundation.
ICS–Africa (Investing in Children and their Societies - Africa), a Dutch NGO, operationalized the delivery system and payment of the subsidy.
Source: http://www.poverty-action.org/study/nudging-farmers-use-fertilizer-experimental-evidence-kenya